Showing 201 - 220 results of 70,284 for search '(( a point decrease ) OR ( 5 ((((we decrease) OR (teer decrease))) OR (a decrease)) ))', query time: 0.98s Refine Results
  1. 201

    Image_4_Tocilizumab (TCZ) Decreases Angiogenesis in Rheumatoid Arthritis Through Its Regulatory Effect on miR-146a-5p and EMMPRIN/CD147.jpeg by Devy Zisman (11838428)

    Published 2021
    “…In vitro, the accumulation in the supernatants of the pro-angiogenic factors EMMPRIN, VEGF and MMP-9 was increased by co-culturing the HT1080 fibroblasts and the U937 monocytes, while the accumulation of the anti-angiogenic factor thrombospondin-1 (Tsp-1) and the expression levels of miR-146a-5p were reduced. Transfection of HT1080 cells with the miR-146a-5p mimic, decreased the accumulation of EMMPRIN, VEGF and MMP-9. …”
  2. 202

    Image_2_Tocilizumab (TCZ) Decreases Angiogenesis in Rheumatoid Arthritis Through Its Regulatory Effect on miR-146a-5p and EMMPRIN/CD147.jpeg by Devy Zisman (11838428)

    Published 2021
    “…In vitro, the accumulation in the supernatants of the pro-angiogenic factors EMMPRIN, VEGF and MMP-9 was increased by co-culturing the HT1080 fibroblasts and the U937 monocytes, while the accumulation of the anti-angiogenic factor thrombospondin-1 (Tsp-1) and the expression levels of miR-146a-5p were reduced. Transfection of HT1080 cells with the miR-146a-5p mimic, decreased the accumulation of EMMPRIN, VEGF and MMP-9. …”
  3. 203

    Image_1_Tocilizumab (TCZ) Decreases Angiogenesis in Rheumatoid Arthritis Through Its Regulatory Effect on miR-146a-5p and EMMPRIN/CD147.jpeg by Devy Zisman (11838428)

    Published 2021
    “…In vitro, the accumulation in the supernatants of the pro-angiogenic factors EMMPRIN, VEGF and MMP-9 was increased by co-culturing the HT1080 fibroblasts and the U937 monocytes, while the accumulation of the anti-angiogenic factor thrombospondin-1 (Tsp-1) and the expression levels of miR-146a-5p were reduced. Transfection of HT1080 cells with the miR-146a-5p mimic, decreased the accumulation of EMMPRIN, VEGF and MMP-9. …”
  4. 204

    A multicopy <i>ASH1</i> plasmid increases <i>ASH1</i> mRNA and decreases <i>HO</i> mRNA levels. by Emily J. Parnell (6803422)

    Published 2020
    “…<i>ASH1</i> mRNA analysis under conditions of <i>ASH1</i> overexpression, using cell samples identical to those in <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1009133#pgen.1009133.g001" target="_blank">Fig 1E</a> (Tup1-V5 ChIP analysis). …”
  5. 205
  6. 206
  7. 207
  8. 208
  9. 209
  10. 210

    Mean decrease in accuracy (MDA) of top 15 urine metabolites. by Liam E. Broughton-Neiswanger (8447220)

    Published 2020
    “…Urine metabolites with a mean decrease in accuracy ≥ 0.004 in at least one post-treatment time point (2–5) were considered for inclusion in the predictive model.…”
  11. 211

    Amplitude for A/L = 0.29. by Muhammad Hammad Bucha (21736111)

    Published 2025
    “…The smoothest cylinder (K<sub>s</sub>/D = ) produced the highest power (52.325 µW), while the roughest (K<sub>s</sub>/D = ) resulted in a 6.26% decrease in power (36.4 µW), along with reductions of 4.5% in flapping frequency and 20% in amplitude. …”
  12. 212

    Amplitude for A/L = 0.338. by Muhammad Hammad Bucha (21736111)

    Published 2025
    “…The smoothest cylinder (K<sub>s</sub>/D = ) produced the highest power (52.325 µW), while the roughest (K<sub>s</sub>/D = ) resulted in a 6.26% decrease in power (36.4 µW), along with reductions of 4.5% in flapping frequency and 20% in amplitude. …”
  13. 213

    Amplitude for A/L = 0.02. by Muhammad Hammad Bucha (21736111)

    Published 2025
    “…The smoothest cylinder (K<sub>s</sub>/D = ) produced the highest power (52.325 µW), while the roughest (K<sub>s</sub>/D = ) resulted in a 6.26% decrease in power (36.4 µW), along with reductions of 4.5% in flapping frequency and 20% in amplitude. …”
  14. 214

    Amplitude for A/L = 0.03. by Muhammad Hammad Bucha (21736111)

    Published 2025
    “…The smoothest cylinder (K<sub>s</sub>/D = ) produced the highest power (52.325 µW), while the roughest (K<sub>s</sub>/D = ) resulted in a 6.26% decrease in power (36.4 µW), along with reductions of 4.5% in flapping frequency and 20% in amplitude. …”
  15. 215

    Image_1_miR-144-5p and miR-451a Inhibit the Growth of Cholangiocarcinoma Cells Through Decreasing the Expression of ST8SIA4.tif by Wan Fu (3681799)

    Published 2021
    “…This study aimed to investigate the action mechanism of miR-144-5p and miR-451a in cholangiocarcinoma. We found that miR-144-5p and miR-451a were significantly decreased in cholangiocarcinoma patient samples compared to the adjacent normal bile duct samples. …”
  16. 216

    Image_4_miR-144-5p and miR-451a Inhibit the Growth of Cholangiocarcinoma Cells Through Decreasing the Expression of ST8SIA4.tif by Wan Fu (3681799)

    Published 2021
    “…This study aimed to investigate the action mechanism of miR-144-5p and miR-451a in cholangiocarcinoma. We found that miR-144-5p and miR-451a were significantly decreased in cholangiocarcinoma patient samples compared to the adjacent normal bile duct samples. …”
  17. 217

    Image_3_miR-144-5p and miR-451a Inhibit the Growth of Cholangiocarcinoma Cells Through Decreasing the Expression of ST8SIA4.tif by Wan Fu (3681799)

    Published 2021
    “…This study aimed to investigate the action mechanism of miR-144-5p and miR-451a in cholangiocarcinoma. We found that miR-144-5p and miR-451a were significantly decreased in cholangiocarcinoma patient samples compared to the adjacent normal bile duct samples. …”
  18. 218

    Image_2_miR-144-5p and miR-451a Inhibit the Growth of Cholangiocarcinoma Cells Through Decreasing the Expression of ST8SIA4.tif by Wan Fu (3681799)

    Published 2021
    “…This study aimed to investigate the action mechanism of miR-144-5p and miR-451a in cholangiocarcinoma. We found that miR-144-5p and miR-451a were significantly decreased in cholangiocarcinoma patient samples compared to the adjacent normal bile duct samples. …”
  19. 219
  20. 220